DaVita, Renal Care Group Under Investigation By U.S. Attorney In Brooklyn
This article was originally published in The Pink Sheet Daily
Executive Summary
Both dialysis firms have been asked to produce documents related to vitamin D therapies and testing for parathyroid hormone levels. DaVita is requesting a meeting with DoJ to discuss the scope of the subpoena and the production of documents.